期刊文献+

胰腺癌组织中CD44s和ESA的表达及其与临床病理特征的关系 被引量:1

The expressions of CD44s and ESA and the relationship with clinicopathological characteristics in pancreatic carcinoma
下载PDF
导出
摘要 目的:探讨CD44s和ESA在胰腺癌组织中表达及其与临床病理特征的关系。方法:应用免疫组化SP法检测20例癌旁组织和50例胰腺癌组织中CD44s和ESA的表达。结果:CD44s和ESA在胰腺癌中的表达明显高于癌旁正常组织中的表达,CD44s的表达与淋巴结转移和病理分级有关(P<0.05);而ESA的表达仅与病理分级有关(P<0.05);两者之间表达呈正相关(P=0.017,rs=5.747)。结论:CD44s和ESA在胰腺的发生发展、浸润转移中密切相关,发挥重要作用,两者可作为胰腺癌浸润、转移及评估预后的指标。 Objective:To investigate the expressions of CD44s and ESA and the relationship between their expressions and clinicopathological characteristics in pancreatic carcinoma. Methods:Expressions of CD44s and ESA in 20 cases of pancreatic paraneoplastic tissues and 50 cases of pancreatic carcinoma were detected by immunohistocbemical method. Results:The expressions of CD44s and ESA in pancreatic carcinoma were significantly higher than in pancreatic paraneoplastic tissues. Significant relationship was found among the expression of CD44s and lymphatica metastasis, pathological grade ( P 〈 0.05 ). The expression of ESA was correlated with pathological grade ( P 〈 0.05 ). There was a positive correlation between the expressions of ESA and CD44s (P = 0.017, rs = 5. 747 ). Conclusion:The expressions of ESA and CD44s were highly related to occurrence, development, infiltration and metastasis of pancreatic carcinoma. Both of them might play an important role in the progression of human pancreatic carcinomas and participate in the invasion and metastasis of pancreatic carcinoma.
出处 《现代肿瘤医学》 CAS 2010年第3期520-522,共3页 Journal of Modern Oncology
关键词 CD44S ESA 胰腺癌 免疫组织化学 ESA CD44 immunohistoehemistry pancreatic carcinoma
  • 相关文献

参考文献10

  • 1Koopmann J, Fedarko NS, Lain A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma [ J ]. Cancer Epidemiol Biomarkers Prey,2004,13 (3) :487 - 491.
  • 2Chan AO, Lain SK, Chu KM, et al. Soluble E - cadherin is a valid prognosis marker in gastric carcinoma [ J ]. Gut, 2001,48 : 808 - 811.
  • 3Herrlich P,Zoller M, Donta H, el al. CD44 splice variants : metasta-ses meet lymphocytes [ J ]. lmmunol Today, 1993,14 (8) :395.
  • 4Sereaton GR, Bell MV, Juckson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternative splicedexons [ J]. Proc Nail Acad Sci USA, 1992,89 : 12160 - 12164.
  • 5Gao AC,Lon W,Dong JT,et al. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11 ql 3 [ J ]. Cancer Res, 1997,57 (4) :846 - 849.
  • 6Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective [ J ]. Cancer Res, 2006,66 (21) : 10233 - 10237.
  • 7Patrawala L, Calhoun T, Schneider - Broussard R, et al. Highly purified CD44 + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells[ J]. Oneogene,2006,25 : 1696 - 1708.
  • 8Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis a look out - side the nucleus [ J ]. Science,2000,287 (5458) : 1606 -1609.
  • 9Clevers H. Wnt breakers in colon cancer[ J]. Cancer Cell,2004,5 (1):5 -6.
  • 10Kuhn S, Koch M, Nubel T,et al. A complex of EpCAM,claudin - 7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression [ J ]. Mol Cancer Res,2007,5 (6) :553 - 567.

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部